Cargando…
Effects of the Anti-Tumorigenic Agent AT101 on Human Glioblastoma Cells in the Microenvironmental Glioma Stem Cell Niche
Glioblastoma (GBM) is a barely treatable disease due to its profound chemoresistance. A distinct inter- and intratumoral heterogeneity reflected by specialized microenvironmental niches and different tumor cell subpopulations allows GBMs to evade therapy regimens. Thus, there is an urgent need to de...
Autores principales: | Caylioglu, Deniz, Meyer, Rieke Johanna, Hellmold, Dana, Kubelt, Carolin, Synowitz, Michael, Held-Feindt, Janka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037174/ https://www.ncbi.nlm.nih.gov/pubmed/33808494 http://dx.doi.org/10.3390/ijms22073606 |
Ejemplares similares
-
Insights into Gene Regulation under Temozolomide-Promoted Cellular Dormancy and Its Connection to Stemness in Human Glioblastoma
por: Kubelt, Carolin, et al.
Publicado: (2023) -
Sequential Treatment with Temozolomide Plus Naturally Derived AT101 as an Alternative Therapeutic Strategy: Insights into Chemoresistance Mechanisms of Surviving Glioblastoma Cells
por: Hellmold, Dana, et al.
Publicado: (2023) -
Establishment of a Rodent Glioblastoma Partial Resection Model for Chemotherapy by Local Drug Carriers—Sharing Experience
por: Kubelt, Carolin, et al.
Publicado: (2023) -
Entry and exit of chemotherapeutically-promoted cellular dormancy in glioblastoma cells is differentially affected by the chemokines CXCL12, CXCL16, and CX3CL1
por: Adamski, Vivian, et al.
Publicado: (2020) -
Fabrication and Modelling of a Reservoir-Based Drug Delivery System for Customizable Release
por: Hauck, Margarethe, et al.
Publicado: (2022)